期刊文献+

1例重症脑脊液分流器感染患者的药学监护

原文传递
导出
摘要 目的:探讨对特殊患者实施药学监护的方法和意义。方法:为1例重症脑脊液分流器感染患者提供药学监护,并对患者进行用药分析。结果:临床药师可以从药物不良反应,治疗药物监测,药动学/药效学和药物稳定性等方面作为切入点,为重症患者提供药学监护。结论:临床药师是治疗团队中的重要组成部分,通过对特殊患者提供药学服务,既提高了自身临床知识,又可发挥药学优势,为医生合理用药提供建议。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第18期1597-1599,共3页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献17

  • 1Ragel BT, Browd SR, Schmidt RH. Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents[J]. J Neurosurg, 2006,105 (2) : 242-247.
  • 2Wang KW,Chang WN, Shin TY, et al. Infection of cerebrospinal fluid shunts: causative pathogens,clinical features and outcomes [J]. Jpn J Infect Dis. 2004,57:44-48.
  • 3Schoenbaum SIC,Gardner P,Shillito J. Infections of cerebrospinal fluid shunts: epidemiology,clinical manifestions,and therapy[J]. J Infect Dis. 1975,131 : 543-552.
  • 4Govender ST, Nathoo N, Van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus [J]. J Neurosurg. 2003,99(5):831-839.
  • 5Micromedex healthcare serie [DB/CD]. Thomson Heahhcare, 2009,141 [2009-10-20].
  • 6Mattoes HM, Kuti JL, Drusano GL, et al. Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem [J]. Clin Ther,2004,26(8) : 1187-1198.
  • 7Rodriguez-Cerrato V, McCoig CC, Michelow IC. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coil meningitis [J]. Antimicrob Agents Chemother, 2001 ,45(11) :3092-3097.
  • 8Kanellakopoulou KK, Pagoulayou A, Stroumpoulis K, et al. Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of human: implication for a bactericidal effect [J]. J Antimicrob Chemother, 2008,61, 1328-1331.
  • 9Barth J, Jager D, Mundkowski R, et al. Single- and multipledose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment [J]. J Antimicrob Chemother, 2008,62 (3) : 575-578.
  • 10Ambrose PG, Grasela DM,Grasela TH,et al. Pharmacodynamics of fluoroquinolones against streptococcus pneumoniae in pa tients with community-acquired respiratory tract infections [J]. Antimicrob Agents Chemother, 2001,45 : 2793-2797.

二级参考文献38

  • 1李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
  • 2George R,Leibrock L,Ebstein M.Long term analysis of cerebrospinal fluid shunt infections.A 25 years experience [J].J Neurosurg,1997,51(6):804 -811.
  • 3Renier D,Lacombe J,Pierre-Kahn A,et al.Factors causing acute shunt infection.Computer analysis of 1174 operations [J].J Neurosurg,1984,61(6):1072-1078.
  • 4Choksey MS,Malik lA.Zero tolerance to shunt infections:can it be achieved? [J].J Neurol Neurosurg Psychiatry,2004,75 (1):87 -91.
  • 5Livni G,Yuhas Y,Ashkenazi S,et al.In vitro bacterial adherence to ventriculoperitoneal shunts [J].Pediatr Neurosurg,2004,40(2):64- 69.
  • 6Wang KW,Chang WN,Shih TY,et al.Infection of cerebrospinal fluid shunts:causative pathogens,clinical features,and outcomes [J].Jpn J Infect Dis,2004,57 (2):44 -48.
  • 7Schreffler RT,Schreffler AJ,Wittler RR.Treatment of cerebrospinal fluid shunt infections:a decision analysis [J].Pediatr Infect Dis J,2002,21(7):632 -636.
  • 8De Bels D,Korinek AM,Bismuth R,et al.Empirical treatment of adult postsurgical nosocomial meningitis[J].Acta Neurochir (Wien),2002,144(10):989 -995.
  • 9Owen R,Pittman T.Delayed external ventriculoperitoneal shunt infection [J].J Ky Med Assoc,2004,102(8):349 -352.
  • 10KUTI J J,NICOLAU D P. Making the most of surveillance studies summary of the OPTAMA program [ J ] . Diagn Microbiol Infect Dis,2005,53(4) :281- 287.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部